Drug
Csl324
Csl324: highest development phase Phase 2, developed by CSL. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- CSL
Trials
| Drug | Phase | Indication |
|---|---|---|
| CSL324 NCT04519424 | Phase 2 | Coronavirus Disease 2019 (COVID-19) |
Latest
No recent events.
Follow Csl324 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.